Drawing for GLYCOSCORE

USPTO serial 79345952

GLYCOSCORE

Reviewed by CopyMark Law Group

Reg. 7171905Status 700Registered
Filing date
Status date
Registration date
Sep 26, 2023
Examiner
ALLEN, BIANCA LEIGH
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with GLYCOSCORE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Joseph M Kuo

161 N. Clark Street, Suite 4200Chicago, IL 60601UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Diagnostic preparations for medical use and diagnostic materials in the nature of diagnostic agents for medical purposes; reagents for use in diagnostic tests for medical purposes; medical diagnostic test strips for blood analysis; chemical preparations for testing blood for medical purposes; in vitro diagnostic preparations for medical use in relation to oncology indications; diagnostic biomarkerACTIVE—
009Downloadable computer and application software in relation to medical testing, namely, for testing cancer cells; downloadable computer and application software for use in tracking medical test results; research laboratory analyzers for measuring, testing and analysing blood and other bodily fluidsACTIVE—
010Medical testing apparatus and equipment for testing cancer cells; blood testing apparatus and blood testing equipment, namely, blood sampling tubes; blood pressure testing apparatus being a diagnostic medical device; medical diagnostic apparatus and equipment in the field of oncology for detecting cancerACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 7, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 29, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jan 22, 2024FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jan 3, 2024FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jan 3, 2024FIMPFINAL DISPOSITION PROCESSED—
Dec 26, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Sep 26, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Sep 26, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 11, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 11, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 10, 2023GPNXNOTIFICATION PROCESSED BY IB—
Jun 21, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jun 21, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jun 21, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 7, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 7, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Jun 7, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 7, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 7, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 5, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 5, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 5, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 25, 2023RFNTREFUSAL PROCESSED BY IB—
Jan 3, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 3, 2023RFRRREFUSAL PROCESSED BY MPU—
Oct 14, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Oct 13, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 5, 2022DOCKASSIGNED TO EXAMINER—
Aug 2, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 29, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 28, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance